K 7259

Known as: K-7259 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-1996
02419941996

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
The effects of dilazep and K-7259, a dilazep derivative, on the haemolysis (as evidenced by release of haemoglobin) induced by… (More)
Is this relevant?
1997
1997
Global ischemia (15 min) followed by reperfusion (10, 20 or 30 min) was performed in isolated, working rat hearts. Ischemia… (More)
Is this relevant?
1996
1996
We studied the effects of dilazep, K-7259 (a novel derivative of dilazep) and d-propranolol on the change in cell shape and… (More)
Is this relevant?
1996
1996
The effect of dilazep, a potentiator of the adenosine-mediated effects, on the hydrogen peroxide (H2O2)-induced mechanical and… (More)
Is this relevant?
1996
1996
The effect of dilazep, a potentiator of the adenosine-mediated effects, on the palmitoyl-L-carnitine (PALCAR)-induced mechanical… (More)
Is this relevant?
Review
1996
Review
1996
The classical understanding of the mechanism of anti-anginal or anti-ischemic drugs is an increase in blood supply to the heart… (More)
Is this relevant?
1995
1995
The effect of K-7259, a novel derivative of dilazep, on the cardiovascular action of adenosine was studied in the aortic ring and… (More)
Is this relevant?
1995
1995
This study was designed to evaluate the relationship between oxygen free radicals and age-related morphological changes in… (More)
Is this relevant?
1994
1994
K-7259 is a dilazep dihydrochloride derivative that minimizes the damaged area from middle cerebral artery hemiocclusion in the… (More)
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?